Articles

Markets and money for scientists

Markets, equity compensation and planning, written for people who want the evidence rather than the hype. New articles about once a month.

Where Are You on the Investor Confidence Curve?

How much you know about money and how confident you feel about it are two different things, and the gap between them shapes almost every financial decision you make.

Continue reading
Behavioral Finance, Dunning-Kruger effect, Fiduciary Advice, Financial Planning, Investor Overconfidence

Peer Review Your Own Financial Plan: A Scientist's Guide

If you would never let a manuscript through review without checking the methods, you shouldn't let your financial plan through without checking them either.

Continue reading
Evidence-based investing, Financial Plan Review, Financial Planning, Planning for Scientists, Retirement Planning, Risk Management

How Would Scientists Make Financial Planning Decisions?

"What is your favorite drink?" I asked a scientist friend. "It is a dirty martini," he replied, "the simplest possible formulation yet endlessly retested. Every bartender tries, in vain, to find a better ratio for it." ...

Continue reading
Behavioral Finance, Decision Making, Evidence-based investing, Financial Planning, Personal Finance

The Flaws That Threaten AI Also Undermine Your Financial Plans

Recent discussions about what it would take for AI to succeed keep returning to one stubborn bottleneck: alignment. Even if compute scales, algorithms improve, and economic value is clear, systems can still fail by optim...

Continue reading
AI alignment, Behavioral Finance, Financial Planning, Goal misgeneralization, Reward hacking

Structural Vulnerabilities in the US Treasuries & Private Credit

As we continually assess the evolving risks shaping portfolios and long-term planning, two interconnected areas warrant close attention: the structural pressures in the US Treasury market amid rising federal debt, and th...

Continue reading
Federal Debt, Fixed Income, Liquidity, Private Credit, Risk, Rollover Risks, US Treasuries

3 Lessons from the US-Israel War on Iran to Save Your Portfolio

The fog of war and the fog of a bear market have more in common than most people realize. In both arenas, pressure reveals whether a strategy was ever real — or just a plan that felt good when stakes were low. As analyst...

Continue reading
Financial Planning, Geopolitical Shifts, Investment Opportunity, Learning, Market Volatility, Personal Finance, Political Uncertainty, Risk, Stock Market, strategy

A Probabilistic Look at the Hybrid Global Order

Great‑power rivalry, economic fragmentation, and transnational instability have converged to create one of the most complex geopolitical environments in decades. More than a decade ago, Joseph S. Nye Jr. captured this em...

Continue reading
China, Geopolitical Shifts, Global Outlook, International, Multipolarity, Power Rivalry, Representative Bias, World Order

Treasury Yield Outlook For A Scientific Mind

The U.S. Treasury market enters 2026 at a pivotal moment. Investors are weighing the effects of Federal Reserve rate cuts, moderating inflation, and persistent fiscal pressures that continue to shape long‑term yields. Th...

Continue reading
Bond Market Outlook, Duration Management, Financial Planning, Fiscal Deficit, Fixed Income, Scientist, Treasury Yield Curve, Uncertainty

Beyond IQ: The Six Drivers of Wealth of Intelligent People

If you’re a scientist—or simply someone with an above‑average IQ—you’ve probably been told that intelligence is a major driver of success. And to some extent, that’s true. There is good news: research shows that higher I...

Continue reading
Collaboration, Decision Making, Financial Planning, High IQ, Intelligence, Learning, Market Volatility, Personal Finance, Risk, Scientist

S&P 500 Targets for 2026: Optimism, AI Tailwinds & Reality Checks

As 2025 winds down and the S&P 500 hovers in the 6,800–6,900 range, it’s hard not to look ahead and wonder what 2026 has in store. This year has been another strong one—AI-driven productivity gains, resilient earnings, a...

Continue reading
Asset Classes, Financial Planning, Market Volatility, Risk, S&P500, Stock Market, Year-end Targets

Warren Buffett’s 2025 Shareholder Wisdom: Markets & Succession

The legendary Woodstock for Capitalists took place on May 3 in Omaha, Nebraska, drawing nearly 20,000 attendees eager to hear Warren Buffett’s wisdom. Here are some of the most insightful moments I captured from the meet...

Continue reading
Apple, Berkshire Hathaway, Fiscal Deficit, Free Trade, Insurance, Market Volatility, Succession Planning, Warren Buffett

How China's M2 boom will shape the global financial markets?

China’s monetary landscape is undergoing a dramatic shift. As of March 2025, the country’s M2 money supply—encompassing cash, checking deposits, and near-liquid assets like savings and time deposits—has surged to an asto...

Continue reading
Asset Classes, China, Commodities, Emerging Markets, Equity, Investment Opportunity, Liquidity, Money Supply, Stock Market

Strategic Autonomy vs. Policy Uncertainty: US/EU Defense Divide

The defense sector, long a cornerstone of global markets, is witnessing a striking divergence in 2025. European defense stocks are soaring, fueled by aggressive rearmament and a push for strategic autonomy, while U.S. de...

Continue reading
Aerospace, Defense Stocks, ETFs, European Defense, Geopolitical Shifts, Political Uncertainty, Tarrifs, U.S. Defense

Understanding RSUs: A Guide for Pharmaceutical Employees

Restricted Stock Units (RSUs) are a common part of compensation packages in the pharmaceutical industry, where companies like Pfizer, Amgen, or Gilead Sciences use them to attract and retain top talent. For employees wor...

Continue reading
Equity Compensation, Pharmaceuticals, RSUs, Taxation, Vesting

Navigating the Financial Hurdles of Scientific Careers

In the pursuit of advancing human knowledge, scientists face numerous challenges that extend far beyond the lab bench. From securing funding to combating misinformation, these hurdles impact research outcomes and scienti...

Continue reading
Career Transition, Financial Planning, Funding, Personal Finance, Scientist, Uncertainty

Collaborating with Scientists to Build their Wealth

Science is powered by a rich tapestry of personalities, each bringing unique strengths to the table. Having worked as a scientist for 14 years and now as a financial expert for the past 14 years, I’ve had the privilege o...

Continue reading
Collaboration, Financial Planning, Scientist

5 Essential Financial Lessons for Pharmaceutical Scientists

Are you passionate about building wealth while contributing to groundbreaking medicines? After 10 years in drug discovery research and 15 years in financial planning for pharmaceutical scientists, I've distilled my insights...

Continue reading
Bonus, Career Transition, Financial Planning, Learning, Patent Income, Scientist, Stock Options